Piróth Zsolt, Csanádi Bettina, Bora Noémi, Németh Orsolya, Gál Róbert
1 Gottsegen György Országos Kardiovaszkuláris Intézet Budapest, Haller u. 29., 1096 Magyarország.
2 Semmelweis Egyetem, Doktori Iskola Budapest Magyarország.
Orv Hetil. 2024 Oct 13;165(41):1613-1620. doi: 10.1556/650.2024.33131.
Angina and myocardial ischemia as detected by non-invasive modalities frequently occur in individuals without significant (obstructive) epicardial coronary artery disease. These are caused by microvascular coronary artery disease, coronary vasospasm, or a combination thereof. Patients suffering from these conditions have a poor quality of life, and prognosis, and frequently need rehospitalization which poses a significant burden on the healthcare system. It is now clear that the pathomechanism of these conditions can be objectively and quantitatively elucidated by invasive coronary thermodilution techniques and provocation tests. Recent publications and consensus documents have crystallized the diagnostic criteria of microvascular coronary artery disease and vasospastic angina. Systematic application of the diagnostic workup proposed by working groups makes it possible to identify individuals who benefit from medical therapies aimed at the pathomechanism thereby improving the quality of life of these patients. The present review summarizes the epidemiology, prognosis, and pathomechanism of microvascular coronary artery disease and vasospastic angina; provides a detailed, technical analysis of the invasive diagnostic modalities, the parameters of microvascular function applied in everyday practice, their background and caveats. The diagnostic aspects are complemented by pharmacologic approaches to treating these conditions available today and in the pipeline. Orv Hetil. 2024; 165(41): 1613–1620.
通过非侵入性检查发现的心绞痛和心肌缺血在没有明显(阻塞性)心外膜冠状动脉疾病的个体中经常出现。这些是由微血管冠状动脉疾病、冠状动脉痉挛或两者共同引起的。患有这些疾病的患者生活质量差,预后不良,并且经常需要再次住院,这给医疗系统带来了沉重负担。现在很清楚,这些疾病的发病机制可以通过有创冠状动脉热稀释技术和激发试验进行客观和定量的阐明。最近的出版物和共识文件已经明确了微血管冠状动脉疾病和血管痉挛性心绞痛的诊断标准。工作组提出的诊断检查方法的系统应用使得识别那些从针对发病机制的药物治疗中获益的个体成为可能,从而改善这些患者的生活质量。本综述总结了微血管冠状动脉疾病和血管痉挛性心绞痛的流行病学、预后和发病机制;对有创诊断方法、日常实践中应用的微血管功能参数、其背景和注意事项进行了详细的技术分析。今天以及正在研发中的治疗这些疾病的药物方法补充了诊断方面的内容。《匈牙利医学周报》。2024年;165(41):1613 - 1620。